Patients with HBV reactivation-related hepatitis have been reported to have lower peaks of ALT and albumin levels, and higher HBV DNA levels, at the initiation of hepatitis and to be more likely to progress to acute liver failure with high morbidity and mortality, compared to patients with acute hepatitis B [6]. The gene discussed is GPT; the disease is hepatitis B virus infection.